The success of CAR-T therapy requires robust expansion of specific subpopulations of immune cells derived from the patient. The use of serum introduces a host of problems, including:

• Variability 
• Lack of reproducibility 
• Increased risk to the patient

Find out about the benefits of a xeno- and serum-free medium for process control and for selective expansion of cell subpopulations.